Hansa Biopharma
Hansa Biopharma is a commercial-stage biopharmaceutical company developing and commercializing treatments for patients with rare immunological conditions.
- Headquarters
- Lund, SwedenSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 51 to 200Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2007Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 20 supported appearances ↗Source: RevenueBase lists
What does Hansa Biopharma do?
The company is developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy. The company is exploring potential applications of its technology platform in oncology.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
#1 Biotechnology companies with development operations
Snapshot: September 15, 2026
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 6, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 17, 2026, September 19, 2026, September 27, 2026, October 7, 2026 and October 8, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.